
DEA Portal Draws 400 Cannabis Operators in First Three Days
Medical marijuana businesses rush to register ahead of June deadline for 280E tax relief
Nearly 400 cannabis businesses registered with the DEA's new Medical Marijuana Dispensary Registration Portal within 72 hours of its launch, signaling widespread industry interest in securing federal recognition under rescheduling.
The registration surge comes as operators race to meet a June 26 deadline tied to the Trump administration's April 23 order moving state-licensed medical cannabis from Schedule I to Schedule III. The shift ends decades of punitive tax treatment under Internal Revenue Code Section 280E for qualifying medical marijuana operators.
280E has long prevented cannabis businesses from deducting ordinary business expenses like rent, salaries, and marketing costs—forcing many to pay effective tax rates exceeding 70%. Research from the Marijuana Policy Project estimates the provision has cost state-licensed operators billions in additional federal taxes since the early 2000s.
The Registration Window
The DEA portal opened earlier this month following weeks of uncertainty about implementation timelines. Businesses must complete registration by June 26 to qualify for immediate 280E relief under the rescheduling order.
Operators registering after the deadline may face delays in securing tax benefits, though the DEA has not clarified whether late registrants would be retroactively penalized. The agency's guidance indicates registration requires proof of state medical marijuana licensure, business entity documentation, and facility information.
Adult-use recreational dispensaries remain excluded from the registration process and continue facing 280E restrictions. The Schedule III designation applies only to state-licensed medical marijuana programs, creating a two-tier system within the industry.
Industry Response
Cannabis trade organizations have pushed members to register quickly, warning that processing delays could push some applications past the June deadline. The National Cannabis Industry Association distributed registration guides to members within hours of the portal's launch.
But questions remain about long-term implications. Some operators worry federal registration could expose them to additional DEA oversight or create compliance complications if future administrations reverse rescheduling policies.
Multi-state operators face particular complexity. Companies with both medical and recreational licenses in different states must navigate which facilities qualify for registration—and whether mixing registered and unregistered operations creates accounting headaches.
What's Next
The DEA has not disclosed how many registrations it expects to process by the June deadline or whether it will extend the registration window. Agency officials said the portal will remain open beyond June 26, but emphasized that late registrants may not receive immediate tax relief.
Tax attorneys are advising clients to register even if uncertain about eligibility, noting that rejected applications are preferable to missing the deadline entirely. The IRS has not yet issued formal guidance on how registered businesses should modify their 2025 tax filings.
Meanwhile, congressional Democrats have criticized the registration requirement as an unnecessary hurdle, arguing that rescheduling should automatically extend tax relief to all state-licensed medical operators. Republican lawmakers have largely remained silent on implementation details.
The 400 early registrations represent a fraction of the estimated 3,000-plus medical marijuana dispensaries operating nationwide, suggesting many operators are still evaluating whether federal registration aligns with their business strategies.
This article is based on original reporting by hightimes.com.
Original Source
This article is based on reporting from High Times.
Read the original articleOriginal title: "The DEA Just Opened A Door To Federal Cannabis. Nearly 400 Businesses Are Already Racing Through It."
Related Topics
Related Stories
White House Drug Strategy Targets High-THC Products, Cartel Activity
The White House's new drug strategy targets high-THC cannabis products and warns about cartel exploitation of state markets, even as federal rescheduling remains pending and hemp THC bans approach.
Legislation15,000 March in Mexico City as Cannabis Legalization Stalls
An estimated 15,000 protesters marched through Mexico City demanding cannabis legalization legislation that Congress has failed to pass despite a 2021 Supreme Court deadline declaring prohibition unconstitutional.
DEA Officially Classifies HHC as Schedule I Controlled Substance
DEA formally classifies HHC as Schedule I controlled substance, declaring the synthetic cannabinoid illegal despite hemp origins and closing a loophole manufacturers used to market products as legal alternatives.
More from Dr. Maya Patel, PharmD
View all articlesSurgeon General Nominee Linked Cannabis to Gynecomastia in Past Remarks

Neuroscientist Maps 10,000 Years of Cannabis Medicine Lost to Prohibition

Survey of 3,500 Patients Shows Medical Cannabis Reduces Prescription Drug Use

